[CHM] YoY Quarter Result on 30-Jun-2022 [#Q4]

Stock
[CHM] Chimeric Therapeutics Limited
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- 35.92%
YoY- 46.06%
Quarter Report
CHM's Result
CHM's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue -1,756 706 1,309 0 0 -
PBT -12,809 -15,592 -6,046 -11,511 -32 346.83%
Tax 2,165 -1,423 164 5,682 -77 -
NP -14,974 -14,169 -6,209 -11,511 -32 364.61%
Tax Rate - - - - - -
Total Cost 13,217 14,875 7,518 11,511 32 350.34%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 852.53 -2,007.51 -474.53 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.02 -0.03 -0.02 -0.03 -0.00 -
EPS Diluted -0.02 -0.03 -0.02 -0.03 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.